Learn more about our Legal work.
WASHINGTON—AdvaMed, the MedTech Association®, the world’s largest medtech trade association, representing over 650 medical technology innovators, has filed an amicus curiae brief in the Walker v. Becton, Dickinson and Company…
AdvaMed® comment letter to the OIG’s recommends updates to safe harbors, value-based arrangements, & oversight to support value-driven healthcare.
This comment letter fromAdvaMed® responds to the OSTP’s Request for Information on National Strategic Plan for Advanced Manufacturing (“OSTP RFI”).
Supreme Court Term in Review: Implications for the Medical Technology Industry
WASHINGTON, D.C. – AdvaMed, the Medtech Association, today announced that its board of directors has unanimously approved revisions to theAdvaMed® Code of Ethics on Interactions with Health Care Professionals.
AdvaMed® was honored to address delegates at the 12th Asia-Pacific Economic Cooperation (APEC) Business Ethics for SMEs Forum held in Seoul, Korea, on September 8-9, 2025.AdvaMed® galvanized delegates from across…
Washington, D.C.—AdvaMed, the MedTech Association®, asked the US District Court for the District of Massachusetts to rule as a matter of law that independent sales agent (ISA) arrangements do not…
Christopher L. White, Esq., AdvaMed’s General Counsel & Chief Policy Officer, on why this year’s legal, compliance & regulatory programming is mission-critical as medtech leaders navigate uncertainty, shifting enforcement priorities,…
Washington, DC.—AdvaMed, the MedTech Association®, asked the Court of Appeals for the Third Circuit to vacate the judgment of the District Court, which if allowed to stand, would have significant…